274 related articles for article (PubMed ID: 29791107)
1. [PHARMACOGENETIC MARKERS OF THE EFFECTIVENESS OF TREATMENT OF CHILDREN WITH ATOPIC BRONCHIAL ASTHMA.].
Balabolkin II; Bulgakova VA
Eksp Klin Farmakol; 2016; 79(11):35-40. PubMed ID: 29791107
[TBL] [Abstract][Full Text] [Related]
2. For patients with chronic asthma not controlled with inhaled corticosteroids alone, long-acting β-agonists are associated with fewer exacerbations than leukotriene receptor agonists.
Colice G
Evid Based Med; 2014 Oct; 19(5):174. PubMed ID: 24917602
[No Abstract] [Full Text] [Related]
3. Pharmacogenetics of asthma.
Hawkins GA; Peters SP
Methods Mol Biol; 2008; 448():359-78. PubMed ID: 18370237
[TBL] [Abstract][Full Text] [Related]
4. Genetics and the variability of treatment response in asthma.
Israel E
J Allergy Clin Immunol; 2005 Apr; 115(4 Suppl):S532-8. PubMed ID: 15806036
[TBL] [Abstract][Full Text] [Related]
5. The pharmacogenetics of asthma treatment.
Tantisira K; Weiss S
Curr Allergy Asthma Rep; 2009 Jan; 9(1):10-7. PubMed ID: 19063819
[TBL] [Abstract][Full Text] [Related]
6. Treatment response heterogeneity in asthma: the role of genetic variation.
Vijverberg SJH; Farzan N; Slob EMA; Neerincx AH; Maitland-van der Zee AH
Expert Rev Respir Med; 2018 Jan; 12(1):55-65. PubMed ID: 29115880
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of asthma.
Palmer LJ; Silverman ES; Weiss ST; Drazen JM
Am J Respir Crit Care Med; 2002 Apr; 165(7):861-6. PubMed ID: 11934710
[No Abstract] [Full Text] [Related]
8. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
Murray CS; Thomas M; Richardson K; Price DB; Turner SW
J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
[TBL] [Abstract][Full Text] [Related]
9. Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.
Turner S; Francis B; Vijverberg S; Pino-Yanes M; Maitland-van der Zee AH; Basu K; Bignell L; Mukhopadhyay S; Tavendale R; Palmer C; Hawcutt D; Pirmohamed M; Burchard EG; Lipworth B;
J Allergy Clin Immunol; 2016 Jul; 138(1):107-113.e5. PubMed ID: 26774659
[TBL] [Abstract][Full Text] [Related]
10. How pharmacogenomics will play a role in the management of asthma.
Wechsler ME; Israel E
Am J Respir Crit Care Med; 2005 Jul; 172(1):12-8. PubMed ID: 15778484
[No Abstract] [Full Text] [Related]
11. [Molecular and pharmacogenetic mechanisms of severe asthma].
Kulikov ES; Ogorodova LM; Freĭdin MB; Deev IA; Selivanova PA; Fedosenko SV; Kirillova NA
Vestn Ross Akad Med Nauk; 2013; (3):15-23. PubMed ID: 23808266
[TBL] [Abstract][Full Text] [Related]
12. β2-Adrenergic receptor Gly16Arg polymorphism and impaired asthma control in corticosteroid-treated asthmatic adults.
Manoharan A; Griffin B; Lipworth J; Berg J; Andrew N; Jackson C; Lipworth B
Ann Allergy Asthma Immunol; 2015 May; 114(5):421-3. PubMed ID: 25747787
[No Abstract] [Full Text] [Related]
13. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z; Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
[TBL] [Abstract][Full Text] [Related]
14. Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies.
Albers FC; Price RG; Smith SG; Yancey SW
J Allergy Clin Immunol; 2017 Nov; 140(5):1464-1466.e4. PubMed ID: 28687231
[No Abstract] [Full Text] [Related]
15. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
[TBL] [Abstract][Full Text] [Related]
16. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
17. The pharmacogenetics of asthma therapy.
Tantisira KG; Weiss ST
Curr Drug Targets; 2006 Dec; 7(12):1697-708. PubMed ID: 17168844
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of asthma.
Lima JJ; Blake KV; Tantisira KG; Weiss ST
Curr Opin Pulm Med; 2009 Jan; 15(1):57-62. PubMed ID: 19077707
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
Currie GP; Lee DK; Menzies D; Lipworth BJ
Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
[No Abstract] [Full Text] [Related]
20. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No.
Wenzel SE
Am J Respir Crit Care Med; 1998 Dec; 158(6):1699-701. PubMed ID: 9847255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
